-
My Account
My Account
BSE Live
Apr 20, 16:00Prev. Close
399.25
Open Price
408.00
Bid Price (Qty.)
479.10 (10829)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 20, 15:58Prev. Close
399.35
Open Price
405.30
Bid Price (Qty.)
477.70 (45871)
Offer Price (Qty.)
0.00 (0)
| Quarterly Results of RPG Life Sciences (in Rs. Cr.) | Dec '20 | Sep '20 | Jun '20 | Mar '20 | Dec '19 | |
| Net Sales/Income from operations | 107.60 | 97.13 | 91.65 | 88.67 | 94.37 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 107.60 | 97.13 | 91.65 | 88.67 | 94.37 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 21.75 | 26.80 | 19.14 | 18.17 | 22.73 | |
| Purchase of Traded Goods | 15.17 | 8.09 | 15.05 | 9.27 | 18.49 | |
| Increase/Decrease in Stocks | 1.31 | -3.92 | -4.92 | 3.08 | -9.32 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 24.37 | 24.41 | 24.00 | 23.68 | 24.17 | |
| depreciat | 4.19 | 4.20 | 4.16 | 4.12 | 4.16 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 23.70 | 22.63 | 21.53 | 21.97 | 23.41 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 17.11 | 14.92 | 12.69 | 8.38 | 10.73 | |
| Other Income | 0.12 | 0.04 | 0.45 | 0.38 | 0.04 | |
| P/L Before Int., Excpt. Items & Tax | 17.23 | 14.96 | 13.14 | 8.76 | 10.77 | |
| Interest | 0.16 | 0.23 | 0.31 | 0.30 | 0.36 | |
| P/L Before Exceptional Items & Tax | 17.07 | 14.73 | 12.83 | 8.46 | 10.41 | |
| Exceptional Items | -- | -- | -- | -5.32 | -- | |
| P/L Before Tax | 17.07 | 14.73 | 12.83 | 3.14 | 10.41 | |
| Tax | 4.20 | 3.58 | 3.77 | 0.16 | 2.50 | |
| P/L After Tax from Ordinary Activities | 12.87 | 11.15 | 9.06 | 2.98 | 7.91 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 12.87 | 11.15 | 9.06 | 2.98 | 7.91 | |
| Equity Share Capital | 13.23 | 13.23 | 13.23 | 13.23 | 13.23 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 7.78 | 6.74 | 5.48 | 1.80 | 4.78 | |
| Diluted EPS | 7.78 | 6.74 | 5.48 | 1.80 | 4.78 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 7.78 | 6.74 | 5.48 | 1.80 | 4.78 | |
| Diluted EPS. | 7.78 | 6.74 | 5.48 | 1.80 | 4.78 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
27.01.2021
RPG Life Standalone December 2020 Net Sales at Rs 107.60 crore, up 14.02% Y-o-Y
02.11.2020
RPG Life Sciences shifts gears, bets on chronic drugs to expand sales, profits
03.08.2020
RPG Life Standalone June 2020 Net Sales at Rs 91.65 crore, down 2.54% Y-o-Y
30.12.2019
Breakout buys: SBI, Hindalco among 10 stocks to consider for January series
27.01.2021
RPG Life Standalone December 2020 Net Sales at Rs 107.60 crore, up 14.02% Y-o-Y
03.08.2020
RPG Life Standalone June 2020 Net Sales at Rs 91.65 crore, down 2.54% Y-o-Y
30.07.2019
RPG Life Standalone June 2019 Net Sales at Rs 94.04 crore, up 17.71% Y-o-Y
30.04.2019
RPG Life Standalone March 2019 Net Sales at Rs 68.80 crore, down 17.57% Y-o-Y
